PURE Bioscience, Inc. (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that it will be exhibiting its SDC-based PURE Hard Surface™ disinfectant and food contact surface sanitizer at Booth #4105 of the 2012 World Ag Expo being held February 14-16 in Tulare, California. Tom Myers, Executive Vice President, Sales and Marketing, said, “The growing challenge of controlling microbiological contamination in food is a ‘farm-to-fork’ effort. We believe PURE Hard Surface has application in multiple phases of the food supply chain. The World Ag Expo attracts a wide variety of professionals in agriculture and agribusiness, and we expect to increase market awareness of PURE Hard Surface as an effective and responsible tool against microbial growth, particularly in the production, processing and transport of dairy, produce, meat and poultry products.” U.S. EPA-registered PURE Hard Surface provides an unparalleled combination of high efficacy and low toxicity with 30-second bacterial and viral kill times and 24-hour residual protection. PURE Hard Surface completely kills hazardous food pathogens such as E. coli, Salmonella and Campylobacter, and its active ingredient, SDC, has been determined Generally Recognized as Safe (GRAS) for use as a biocide on food processing equipment, machinery and utensils. PURE Hard Surface eliminates resistant pathogens like MRSA and Carbapenem-resistant Klebsiella pneumoniae (NDM-1) as well as dangerous fungi and viruses including HIV, Hepatitis B, Hepatitis C, Norovirus, Influenza A, Avian Influenza and H1N1. PURE Hard Surface delivers this powerful broad-spectrum efficacy while remaining classified as least-toxic (Category IV) by the US EPA. In addition, PURE Hard Surface does not require rinsing after use and is non-corrosive, non-flammable and non-staining/bleaching. World Ag Expo is the largest annual agriculture exposition. In addition to offering professional seminars and events, the 2012 Expo includes 1,600 exhibitors on 2.5 million square feet of exhibit space. More than 100,000 agriculture professionals are expected to attend this year’s Expo.
About PURE Bioscience, Inc.PURE Bioscience, Inc. develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including Staph (MRSA). PURE’s proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today’s global trend toward industry and consumer use of “green” products while providing competitive advantages in efficacy and safety. Patented SDC is an electrolytically generated source of stabilized ionic silver, which formulates well with other compounds. As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at www.purebio.com. This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project,” "expect" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, the Company’s cash position and liquidity requirements, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.